Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
AKT1 E17K
i
Other names:
AKT1, AKT, PKB, PRKBA, RAC, V-akt murine thymoma viral oncogene homolog 1
Associations
(12)
News
Trials
C3 | Sensitive
D | Sensitive
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
PI3 Kinase Inhibitors
Serine-Threonine Kinase Inhibitors
EGFR
Tyrosine Kinase Inhibitors
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
Cyclin Dependent Kinase Inhibitors
Threonine-Tyrosine Kinase Inhibitors
Cancel
Breast Cancer
Solid Tumor
Triple Negative Breast Cancer
Salivary Gland Cancer
Uterine Corpus Leiomyosarcoma
Estrogen Receptor Positive Breast Cancer
Colorectal Cancer
Melanoma
capivasertib
C3
AKT1 E17K
|
Breast Cancer
|
capivasertib
C3
AKT1 E17K
|
Solid Tumor
|
capivasertib
C3
AKT1 E17K
|
Salivary Gland Cancer
|
capivasertib
C3
AKT1 E17K
|
Uterine Corpus Leiomyosarcoma
|
capivasertib
C3
AKT1 E17K
|
Estrogen Receptor Positive Breast Cancer
|
capivasertib
AN2025
C3
AKT1 E17K
|
Triple Negative Breast Cancer
|
AN2025
TAS-117
C3
AKT1 E17K
|
Breast Cancer
|
TAS-117
atezolizumab + RG7440
C3
AKT1 E17K
|
Breast Cancer
|
atezolizumab + RG7440
palbociclib + ARQ 751
D
AKT1 E17K
|
Breast Cancer
|
palbociclib + ARQ 751
trametinib + palbociclib
D
AKT1 E17K
|
Colorectal Cancer
|
trametinib + palbociclib
cetuximab
C3
AKT1 E17K
|
Colorectal Cancer
|
cetuximab
vemurafenib
C3
AKT1 E17K
|
Melanoma
|
vemurafenib
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
